We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma.
- Authors
Oro-Ayude, Marcos; Suh-Oh, Hae Jin; Sacristán-Santos, Victor; Vázquez-Bartolomé, Patricia; Flórez, Ángeles
- Abstract
Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated with nivolumab. This patient achieved a complete response and continues treatment without progression signs, supporting the notion that PD-1 inhibition can induce long-term remission and is well tolerated in this type of patient.
- Subjects
SQUAMOUS cell carcinoma; DEATH receptors
- Publication
Case Reports in Dermatology, 2020, Vol 12, Issue 1, p37
- ISSN
1662-6567
- Publication type
Article
- DOI
10.1159/000505478